← Back to Search

Educational Sessions for Parkinson's Disease

N/A
Waitlist Available
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months post op
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to determine if an online educational session on Deep Brain Stimulation (DBS) can better inform patients and their caregivers than the current standard methods. The session includes a 1-hour video

Who is the study for?
This trial is for individuals with Parkinson's Disease who are candidates for Deep Brain Stimulation (DBS) surgery. They should be able to attend two online educational sessions about DBS, including a Q&A. The specific inclusion and exclusion criteria are not provided in the details given.
What is being tested?
The study is testing whether virtual learning experiences can help patients set realistic expectations about DBS surgery. It involves two online sessions: an immersive educational video call and a follow-up session for summarizing information and answering questions.
What are the potential side effects?
Since this trial focuses on educational sessions rather than medical interventions, there are no direct side effects related to medication or surgical procedures. However, participants may experience information overload or stress from the content discussed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months post op
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months post op for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
MDS-UPDRS (Movement Disorders Society Unified Parkinson's Disease Rating Scale)
Parkinson Anxiety Scale (PAS)
Structured survey
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Educational GroupExperimental Treatment1 Intervention
Patients will receive two extra virtual educational sessions.
Group II: Standard-of-CareActive Control1 Intervention
Patients will not receive any extra educational sessions. Their education will be provided as per standard-of-care by the clinical team.

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
721 Previous Clinical Trials
1,115,196 Total Patients Enrolled
~10 spots leftby Mar 2025